Related Experiment Video

Updated: Apr 18, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.9K

Advances in targeted therapy for unresectable melanoma: new drugs and combinations

Mengze Hao1, Fengju Song2, Xiaoling Du3

  • 1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Hospital & Institute, Tianjin 30060, PR China; National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute &Hospital, Tianjin 300060, PR China.

Cancer Letters
|January 13, 2015
PubMed

Insights

Advanced melanoma treatment is improving with targeted therapies and immunotherapies. These new approaches offer better outcomes for patients with unresectable melanoma, moving beyond traditional chemotherapy.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Melanoma is an aggressive skin cancer with poor prognosis in advanced stages.
  • Current treatments like dacarbazine (DTIC) show limited efficacy for metastatic melanoma.
  • There is a critical need for novel therapeutic strategies to improve survival rates.

Purpose of the Study:

  • To provide an overview of recent advancements in targeted therapy for unresectable melanoma.
  • To highlight the efficacy of new drugs in managing advanced melanoma.
  • To discuss the potential of targeted agents in improving patient outcomes.

Main Methods:

  • Review of scientific literature on targeted therapies for melanoma.
  • Analysis of clinical trial data for drugs like vemurafenib, dabrafenib, ipilimumab, and trametinib.
  • Synthesis of information on the mechanisms of action and clinical benefits of these agents.

Main Results:

  • Targeted drugs (vemurafenib, dabrafenib) and immunotherapies (ipilimumab, trametinib) demonstrate significant advantages in treating advanced melanoma.
  • These novel therapies offer improved response rates and clinical benefits compared to traditional chemotherapy.
  • Advances in targeted therapy are transforming the management of unresectable melanoma.

Conclusions:

  • Targeted therapy and immunotherapy represent a paradigm shift in treating advanced melanoma.
  • These innovative treatments hold promise for enhancing cure rates and extending survival for patients with unresectable disease.
  • Continued research into targeted agents is crucial for further improving melanoma patient care.
Keywords:
BRAFCTLA-4MEKPD-1/L1PI3K/Akt/mTORc-KIT

More Related Videos

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.5K
A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K